fluorophosphate has been researched along with Osteoporosis, Postmenopausal in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (66.67) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ringe, JD; Setnikar, I | 1 |
Oral, B; Ozbaşar, D | 1 |
Felsenberg, D; Glüer, CC; Mühlenbacher, D; Nickelsen, T; Pavo, I; Payer, J; Quail, D; Reginster, JY; Resch, H; Schmitt, H; Stepan, J | 1 |
Dorst, A; Faber, H; Kipshoven, C; Ringe, JD; Rovati, LC; Setnikar, I | 1 |
Ames, R; Clearwater, J; Cundy, T; Evans, MC; Gamble, GD; Grey, AB; Horne, A; King, A; Orr-Walker, BJ; Reid, IR; Wu, F | 1 |
Grioli, MF; Marsico, S; Pizzo, A; Scriva, D; Sodo, G | 1 |
Baylink, D; Bettica, P; Farley, S; Libanati, C; Resch, H; Tabuenca, M; Talbot, J; Tritthart, W | 1 |
Affinito, P; Di Carlo, C; Napolitano, V; Nappi, C; Petrillo, G; Primizia, M; Tremolaterra, F | 1 |
Battmann, A; Baylink, DJ; Farley, S; Fischer, M; Libanati, CR; Ludy, D; Resch, H | 1 |
Collette, J; Giacovelli, G; Gosset, C; Meurmans, L; Minne, HW; Reginster, JY; Rovati, LC; Setnikar, I; Taquet, AN; Zegels, B | 1 |
Appelboom, T; Avouac, B; Barry, S; Briancon, D; Evreux, JC; Loeb, G; Marchandise, X; Meunier, PJ; Netter, P; Reginster, JY; Rouillon, A; Sebert, JL | 1 |
Lesser, GT | 1 |
Weil, VP | 1 |
Kremling, E; Martini, F; Sell, S | 1 |
Cöster, A; Kipshoven, C; Ringe, JD; Umbach, R | 1 |
Bocanera, R; Masoni, A; Morosano, M; Pera, L; Puche, RC; Rigalli, A; Tozzini, R | 1 |
Alloatti, R; Puche, RC; Rigalli, A | 1 |
Haguenauer, D; Shea, B; Tugwell, P; Welch, V; Wells, G | 1 |
Ringe, JD | 1 |
Meunier, PJ | 1 |
Chapuy, MC; Delmas, PD; Duboeuf, F; Dupuis, J; Meunier, PJ | 1 |
3 review(s) available for fluorophosphate and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Fluoride for treating postmenopausal osteoporosis.
Topics: Bone Density; Female; Fluorides; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Phosphates; Randomized Controlled Trials as Topic; Sodium Fluoride | 2000 |
Past and future of anabolic agents.
Topics: Animals; Calcium; Female; Fluorides; Fractures, Bone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphates; Rats; Retrospective Studies; Sodium Fluoride; Spinal Fractures; Strontium; Time Factors | 2000 |
[The treatment of vertebral osteoporosis. Use of sodium fluoride and sodium monofluorophosphate in combination with calcium].
Topics: Calcium; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Sodium Fluoride; Spinal Diseases | 1990 |
14 trial(s) available for fluorophosphate and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Monofluorophosphate combined with hormone replacement therapy in postmenopausal osteoporosis. An open-label pilot efficacy and safety study.
Topics: Aged; Analgesics; Back Pain; Bone and Bones; Bone Density; Calcium; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Pilot Projects; Spinal Fractures; Treatment Outcome | 2002 |
Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.
Topics: Adult; Aged; Analysis of Variance; Anthropometry; Bone Density; Bone Diseases, Metabolic; Double-Blind Method; Drug Therapy, Combination; Female; Fluorides; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2003 |
Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study.
Topics: Absorptiometry, Photon; Aged; Bone and Bones; Bone Density; Calcaneus; Calcium; Dietary Supplements; Drug Therapy, Combination; Etidronic Acid; Female; Fluorides; Fractures, Spontaneous; Humans; Osteoporosis, Postmenopausal; Pain; Phosphates; Pilot Projects; Range of Motion, Articular; Spinal Fractures; Treatment Outcome; Ultrasonography; Vitamin D | 2005 |
Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.
Topics: Aged; Biopsy; Bone Density; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Fluorides; Follow-Up Studies; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Treatment Outcome | 2007 |
Pharmacokinetic profile of a new fluoride preparation: sustained-release monofluorophosphate.
Topics: Aged; Analysis of Variance; Circadian Rhythm; Delayed-Action Preparations; Double-Blind Method; Female; Fluorides; Humans; Ion-Selective Electrodes; Middle Aged; Osteoporosis, Postmenopausal; Phosphates | 1994 |
A new fluoride preparation for the prevention of postmenopausal osteoporosis: calcium monofluorophosphate.
Topics: Alkaline Phosphatase; Bone Density; Calcium; Female; Fluorides; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Phosphates | 1993 |
Serum fluoride and serum osteocalcin levels in response to a novel sustained-release monofluorophosphate preparation: comparison with plain monofluorophosphate.
Topics: Aged; Delayed-Action Preparations; Double-Blind Method; Female; Fluorides; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Phosphates | 1997 |
The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.
Topics: Aged; Analysis of Variance; Bone Density; Calcium Carbonate; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Fluorides; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Radiography; Spinal Fractures; Thoracic Vertebrae | 1998 |
Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
Topics: Aged; Bone Density; Calcium; Double-Blind Method; Drug Therapy, Combination; Ergocalciferols; Female; Fluorides; Fractures, Spontaneous; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Prospective Studies; Sodium Fluoride; Spinal Fractures; Time Factors | 1998 |
Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate.
Topics: Aged; Body Height; Bone Density; Calcium; Dose-Response Relationship, Drug; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Prospective Studies; Spinal Fractures | 1999 |
In postmenopausal osteoporosis the bone increasing effect of monofluorophosphate is not dependent on serum fluoride.
Topics: Bone Density; Female; Fluorides; Fluorides, Topical; Fluorine; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Sodium Fluoride; Time Factors | 1999 |
Measurement of total and diffusible serum fluoride.
Topics: Aged; Blood Proteins; Diffusion; Electrodes; Fasting; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Protein Binding; Sensitivity and Specificity; Sodium Fluoride | 1999 |
Past and future of anabolic agents.
Topics: Animals; Calcium; Female; Fluorides; Fractures, Bone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphates; Rats; Retrospective Studies; Sodium Fluoride; Spinal Fractures; Strontium; Time Factors | 2000 |
[The treatment of vertebral osteoporosis. Use of sodium fluoride and sodium monofluorophosphate in combination with calcium].
Topics: Calcium; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Sodium Fluoride; Spinal Diseases | 1990 |
6 other study(ies) available for fluorophosphate and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Influence of NaMFP therapy on plasma leptin concentration in postmenopausal women.
Topics: Body Mass Index; Female; Fluorides; Humans; Leptin; Middle Aged; Obesity; Osteoporosis, Postmenopausal; Phosphates | 2002 |
[Postmenopausal osteoporosis. Current therapy protocols].
Topics: Adult; Aged; Calcitonin; Calcium, Dietary; Estrogens; Female; Fluorides; Humans; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Physical Exertion; Progestins | 1994 |
Fluoride for the treatment of osteoporosis.
Topics: Calcium; Drug Therapy, Combination; Female; Fluorides; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Phosphates | 1999 |
Fluoride for the treatment of osteoporosis.
Topics: Bone Density; Female; Fluorides; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Phosphates; Time Factors | 1999 |
Bilateral atraumatic avulsion fracture of the calcaneal tubercle in osteomalacia during fluoride therapy--a case report.
Topics: Achilles Tendon; Calcaneus; Female; Fluorides; Fractures, Spontaneous; Humans; Middle Aged; Osteomalacia; Osteoporosis, Postmenopausal; Phosphates; Radiography; Rupture, Spontaneous | 1999 |
Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
Topics: Aged; Bone Density; Calcium; Drug Therapy, Combination; Female; Fluorides; Fractures, Spontaneous; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Sodium Fluoride; Spinal Diseases | 1990 |